You may not log in without verifying your email address.
Please check your email (including your spam email) for the Welcome message that was sent.
Cisplatin is a potent platinum-based anti-neoplastic agent that is believed to form inter- and intrastrand DNA adducts which activate signaling pathways culminating in apoptosis. The compound has also been shown to induce apoptosis through caspase-3 activation and XIAP expression. Also shown to cause immunosuppression which is thought to be followed by an increase in the host immune response. Platinated DNA adducts also enhance poisoning of DNA topoisomerase I by camptothecin (sc-200871). Cisplatin was the first member of a class of anticancer drugs, which now include carboplatin (sc-202093) and oxaliplatin (sc-202270), that form DNA adducts resulting in apoptosis; however, these molecules also bind other biological molecules such as enzymes which might play a role in their mechanism of action.
1. Bagasra, O., et al. 1985. Cancer Immunol. Immunother. 19: 142-147. PMID: 3157438
2. Bose, R.N. 2002. Mini Rev Med Chem. 2: 103-111. PMID: 12370072
3. Siddik, Z.H. 2003. Oncogene. 22: 7265-7279. PMID: 14576837
4. van Waardenburg, R.C., et al. 2004. J. Biol. Chem. 279: 54502-54509. PMID: 15471886
다른 사용자의 Cisplatin사용법보기. 클릭하여 PubMed entry보기 .
PMID: # 31374291 Li, X.|He, S.|Tian, Y.|Weiss, RM.|Martin, DT.| et al. 2019. Cell. Signal. 63: 109381.
PMID: # 29620162 Yang, X. et al. 2018. Int. J. Oncol. 52: 2021-2030.
PMID: # 29106395 2018. Lab. Invest. 98: 63-78.
PMID: # 28265008 Liu, CW. et al. 2017. Mol. Cancer Ther. 16: 1421-1434.
PMID: # 28692634 Westhoff, GL.|Chen, Y.|Teng, NNH.| et al. 2017. Int. J. Gynecol. Cancer. 27: 1602-1609.
PMID: # 29267289 Chen, Y. et al. 2017. PLoS ONE. 12: e0187222.
PMID: # 29132253 İnci, D. et al. 2017. J. Biomol. Struct. Dyn. 1-24.
PMID: # 28567715 Zhao, H. et al. 2017. Cell Oncol (Dordr). 40: 357-365.
PMID: # 28602975 Kollareddy, M.|Sherrard, A.|Park, JH.|Szemes, M.|Gallacher, K.|Melegh, Z.|Oltean, S.|Michaelis, M.|Cinatl, J.|Kaidi, A.|Malik, K.| et al. 2017. Cancer Lett. 403: 74-85.
PMID: # 28339648 Pendergraft, SS. et al. 2017. Biol. Reprod. 96: 720-732.
산타크루즈바이오테크놀러지는 생물의학연구에 필요한 제품을 개발하는 선구자입니다. Toll Free 1-800-457-3801로 연락주세요. Copyright © 2007-2020 Santa Cruz Biotechnology, Inc. 판권소유. "Santa Cruz Biotechnology", 와 Santa Cruz Biotechnology, Inc. 로고, "Santa Cruz Animal Health", "San Juan Ranch", "Supplement of Champions", 및 San Juan Ranch 로고, "Ultracruz", "Chemcruz", "Immunocruz", "Exactacruz"와 "EZ Touch" 는 Santa Cruz Biotechnology, Inc의 등록된 상표입니다. 모든 상표는 각자 소유주의 소유입니다.